160 related articles for article (PubMed ID: 9662422)
1. Involvement of microsomal fatty aldehyde dehydrogenase in the alpha-oxidation of phytanic acid.
Verhoeven NM; Jakobs C; Carney G; Somers MP; Wanders RJ; Rizzo WB
FEBS Lett; 1998 Jun; 429(3):225-8. PubMed ID: 9662422
[TBL] [Abstract][Full Text] [Related]
2. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
[TBL] [Abstract][Full Text] [Related]
3. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome.
Rizzo WB; Heinz E; Simon M; Craft DA
Biochim Biophys Acta; 2000 Dec; 1535(1):1-9. PubMed ID: 11113626
[TBL] [Abstract][Full Text] [Related]
4. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.
Rizzo WB; Craft DA
J Clin Invest; 1991 Nov; 88(5):1643-8. PubMed ID: 1939650
[TBL] [Abstract][Full Text] [Related]
5. Identification of fatty aldehyde dehydrogenase in the breakdown of phytol to phytanic acid.
van den Brink DM; van Miert JN; Dacremont G; Rontani JF; Jansen GA; Wanders RJ
Mol Genet Metab; 2004 May; 82(1):33-7. PubMed ID: 15110319
[TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.
Haug S; Braun-Falco M
Arch Dermatol Res; 2005 Jun; 296(12):568-72. PubMed ID: 15834613
[TBL] [Abstract][Full Text] [Related]
7. Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
Haug S; Braun-Falco M
Gene Ther; 2006 Jul; 13(13):1021-6. PubMed ID: 16525484
[TBL] [Abstract][Full Text] [Related]
8. Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome.
Rizzo WB; Lin Z; Carney G
Chem Biol Interact; 2001 Jan; 130-132(1-3):297-307. PubMed ID: 11306053
[TBL] [Abstract][Full Text] [Related]
9. Fatty aldehyde and fatty alcohol metabolism: review and importance for epidermal structure and function.
Rizzo WB
Biochim Biophys Acta; 2014 Mar; 1841(3):377-89. PubMed ID: 24036493
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of recombinant human fatty aldehyde dehydrogenase: implications for Sjögren-Larsson syndrome.
Lloyd MD; Boardman KD; Smith A; van den Brink DM; Wanders RJ; Threadgill MD
J Enzyme Inhib Med Chem; 2007 Oct; 22(5):584-90. PubMed ID: 18035827
[TBL] [Abstract][Full Text] [Related]
11. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sj-ogren-Larsson syndrome.
James PF; Zoeller RA
J Biol Chem; 1997 Sep; 272(38):23532-9. PubMed ID: 9295289
[TBL] [Abstract][Full Text] [Related]
12. Bezafibrate induces FALDH in human fibroblasts; implications for Sjögren-Larsson syndrome.
Gloerich J; Ijlst L; Wanders RJ; Ferdinandusse S
Mol Genet Metab; 2006; 89(1-2):111-5. PubMed ID: 16837225
[TBL] [Abstract][Full Text] [Related]
13. Sjogren-Larsson syndrome associated hypermelanosis.
Xu YC; Hou JQ; Zhu WJ; Li P
J Cosmet Dermatol; 2020 Apr; 19(4):789-798. PubMed ID: 31697031
[TBL] [Abstract][Full Text] [Related]
14. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.
Rizzo WB; Craft DA; Somer T; Carney G; Trafrova J; Simon M
J Lipid Res; 2008 Feb; 49(2):410-9. PubMed ID: 17971613
[TBL] [Abstract][Full Text] [Related]
15. Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
Rizzo WB
Mol Genet Metab; 2007 Jan; 90(1):1-9. PubMed ID: 16996289
[TBL] [Abstract][Full Text] [Related]
16. A novel assay for the prenatal diagnosis of Sjögren-Larsson syndrome.
van den Brink DM; van Miert JM; Wanders RJ
J Inherit Metab Dis; 2005; 28(6):965-9. PubMed ID: 16435189
[TBL] [Abstract][Full Text] [Related]
17. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
18. Carrier detection for Sjögren-Larsson syndrome.
Kelson TL; Craft DA; Rizzo WB
J Inherit Metab Dis; 1992; 15(1):105-11. PubMed ID: 1583866
[TBL] [Abstract][Full Text] [Related]
19. Studying fatty aldehyde metabolism in living cells with pyrene-labeled compounds.
Keller MA; Watschinger K; Lange K; Golderer G; Werner-Felmayer G; Hermetter A; Wanders RJ; Werner ER
J Lipid Res; 2012 Jul; 53(7):1410-6. PubMed ID: 22508945
[TBL] [Abstract][Full Text] [Related]
20. The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.
Rizzo WB; Carney G; Lin Z
Am J Hum Genet; 1999 Dec; 65(6):1547-60. PubMed ID: 10577908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
